FDA Proposal Sparks Concern Over Unproven Peptide Drugs

The US Food and Drug Administration (FDA) is considering a proposal to ease access to unproven peptide drugs, despite concerns from FDA staff scientists about their safety and efficacy. The proposal, submitted by Health Secretary Robert F. Kennedy Jr. , would give the FDA 'enforcement discretion' on certain peptide drugs, allowing the agency to choose not to enforce current restrictions. This move has raised concerns among experts, who warn that the drugs may cause harm due to lack of sufficient study.